The epidemiology of prostatic cancer. Geographical distribution and time-trends.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMID 2029395)

Published in Acta Oncol on January 01, 1991

Authors

C S Muir1, J Nectoux, J Staszewski

Author Affiliations

1: International Agency for Research on Cancer, Lyon, France.

Associated clinical trials:

Low-Fat Fish Oil Diet for Prostate Cancer Prevention | NCT00798876

Articles citing this

Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium. Am J Epidemiol (2015) 1.87

Promising molecular targets and biomarkers for male BPH and LUTS. Curr Urol Rep (2013) 1.43

Socio-economic and lifestyle factors associated with the risk of prostate cancer. Br J Cancer (2000) 1.33

Migration and prostate cancer: an international perspective. J Natl Med Assoc (1998) 1.21

Prognostic significance of Bcl-2 in clinically localized prostate cancer. Am J Pathol (1996) 1.13

Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J Nutr (2003) 1.08

Cancer clinical outcomes for minority ethnic groups. Br J Cancer Suppl (1996) 1.05

Risk factors for prostate cancer. Nat Clin Pract Urol (2009) 1.03

Analyzing serum-stimulated prostate cancer cell lines after low-fat, high-fiber diet and exercise intervention. Evid Based Complement Alternat Med (2011) 1.03

Case-control study of risk factors for prostate cancer. Br J Cancer (1996) 0.99

Joint spatial survival modeling for the age at diagnosis and the vital outcome of prostate cancer. Stat Med (2008) 0.92

Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat model. J Nutr Biochem (2011) 0.92

Impact of consumption of vegetable, fruit, grain, and high glycemic index foods on aggressive prostate cancer risk. Nutr Cancer (2011) 0.92

A diet, physical activity, and stress reduction intervention in men with rising prostate-specific antigen after treatment for prostate cancer. Cancer Epidemiol (2011) 0.92

Anti-inflammatory activity of soy and tea in prostate cancer prevention. Exp Biol Med (Maywood) (2010) 0.87

Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study. Asian J Androl (2009) 0.87

Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group. Postgrad Med J (1995) 0.86

Biological mediators of effect of diet and stress reduction on prostate cancer. Integr Cancer Ther (2008) 0.84

Association between prostate cancer and urinary calculi: a population-based study. PLoS One (2013) 0.81

Oxidative balance score and risk for incident prostate cancer in a prospective U.S. cohort study. Ann Epidemiol (2014) 0.80

Isoflavones and Prostate Cancer: A Review of Some Critical Issues. Chin Med J (Engl) (2016) 0.79

Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy. Br J Cancer (1994) 0.79

Consumption of deep-fried foods and risk of prostate cancer. Prostate (2013) 0.79

Is the Expression of Androgen Receptor Protein Associated With the Length of AC Repeats in the Type III 5-α Reductase Gene in Prostate Cancer Patients? Korean J Urol (2013) 0.79

The impact of nutrition in urogenital cancers. Arch Med Sci (2015) 0.78

Differences in prostate cancer detection between Canadian and Saudi populations. Braz J Med Biol Res (2013) 0.78

Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study. Cancer Causes Control (2012) 0.78

Epigenetic influences in the aetiology of cancers arising from breast and prostate: a hypothesised transgenerational evolution in chromatin accessibility. ISRN Oncol (2013) 0.77

Complementary medicine for prostate cancer: effects of soy and fat consumption. Rev Urol (2001) 0.76

Plasma carotenoids and tocopherols in relation to prostate-specific antigen (PSA) levels among men with biochemical recurrence of prostate cancer. Cancer Epidemiol (2015) 0.76

Pattern of prostate cancer presentation among the Egyptian population: A study in a single tertiary care center. Cent European J Urol (2014) 0.75

Risk and preventive factors for prostate cancer in Japan: The Japan Public Health Center-based prospective (JPHC) study. J Epidemiol (2016) 0.75

Articles by these authors

Cancer mortality among the Polish-born in the United States. J Natl Cancer Inst (1965) 2.20

Cancer mortality in 1970-1972 among Polish-born migrants to England and Wales. Br J Cancer (1979) 1.62

Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer (1991) 1.29

International variations in the incidence of childhood bone tumours. Int J Cancer (1993) 1.25

International incidence of childhood brain and spinal tumours. Int J Epidemiol (1994) 1.21

Novel FOXG1 mutations associated with the congenital variant of Rett syndrome. J Med Genet (2009) 1.19

Cancer registration: principles and methods. Classification and coding of neoplasms. IARC Sci Publ (1991) 1.12

Descriptive epidemiology of malignant neoplasms of nose, nasal cavities, middle ear and accessory sinuses. Clin Otolaryngol Allied Sci (1980) 1.12

The relationship between age and major league baseball performance: implications for development. Psychol Aging (1994) 1.09

Cancer mortality in 1962-66 among Polish migrants to Australia. Br J Cancer (1971) 1.07

Smoking and cancer of the alimentary tract in Poland. Br J Cancer (1969) 1.02

Epidemiology, basic science, and the prevention of cancer: implications for the future. Cancer Res (1990) 1.01

Epidemiology of cancer of the testis and penis. Natl Cancer Inst Monogr (1979) 0.97

Smoking and cancer of the urinary bladder in males in Poland. Br J Cancer (1966) 0.93

Age at menarche and breast cancer. J Natl Cancer Inst (1971) 0.91

Impairment of CDKL5 nuclear localisation as a cause for severe infantile encephalopathy. J Med Genet (2007) 0.90

Cancer of the upper alimentary tract and larynx in Poland and in Polish-born Americans. Br J Cancer (1974) 0.90

Re: CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy. Neurology (2009) 0.87

Role of the cancer registry. Natl Cancer Inst Monogr (1977) 0.82

Ovarian cancer; some epidemiological features. World Health Stat Q (1978) 0.78

Breast cancer and body build. Prev Med (1977) 0.78

Cancer of the kidney: international mortality patterns and trends. World Health Stat Q (1980) 0.78

Migrant studies in alimentary tract cancer. Recent Results Cancer Res (1972) 0.76

[Incidence of cancer in children throughout the world]. Pediatrie (1989) 0.76

Prospects for cancer control in the 1990s. Annu Rev Public Health (1990) 0.76

Smoking and Cancer in Poland. Br J Cancer (1960) 0.75

[Mouth and pharyngeal neoplasm mortality]. Nowotwory (1974) 0.75

[General characteristics of patients treated in Oncological Institute in Glivice in 1947-1958]. Nowotwory (1967) 0.75

[Malignant neoplasm mortality in Poland during the years 1970-1974]. Nowotwory (1980) 0.75

Sources of demographic data on migrant groups for epidemiological studies of chronic diseases. J Chronic Dis (1970) 0.75

[Epidemiology of neoplasms in Poland (in the years 1965-7)]. Pol Tyg Lek (1970) 0.75

[Cohort analysis of mortality from lung carcinoma in Poland]. Nowotwory (1978) 0.75

Cancer registration: legal aspects and confidentiality. IARC Sci Publ (1991) 0.75

[Cancer incidence in the Cieszyn Region]. Nowotwory (1975) 0.75

[Epidemiology of stomach carcinoma]. Nowotwory (1975) 0.75

[Inhibitory effect of thiazides on the antidiuretic action of chlorpropamide in a patient with idiopathic diabetes insipidus]. Pol Tyg Lek (1971) 0.75

[Role of mortality statistics in epidemiological studies of neoplasms in Poland]. Pol Tyg Lek (1971) 0.75

[Epidemiology of intestinal and rectal malignant neoplasms]. Nowotwory (1976) 0.75

[Incidence of malignant neoplasms in the Katowice district (excluding the Cieszyn region) 1965-1974]. Nowotwory (1981) 0.75

[Value of mortality statistics in the studies on the epidemiology of cancer]. Nowotwory (1968) 0.75

Evaluation of the action of some drugs on the blood supply of the myocardium in rabbits by means of the test of 125J absorption. Mater Med Pol (1976) 0.75

Cancer mapping: overview and conclusions. Recent Results Cancer Res (1989) 0.75

Influence of Ultracorten H on blood supply of the kidneys in peptone shock and in experimental injury of the heart with silver nitrate in rabbits. Mater Med Pol (1976) 0.75

[Lung cancer mortality increase in Poland]. Nowotwory (1970) 0.75

[Role of labor and breast feeding in the etiopathogenesis of breast carcinoma]. Pol Tyg Lek (1974) 0.75

[Analysis of the incidence of malignant tumors in Katowice district in 1965]. Nowotwory (1970) 0.75

[Dietary habits and stomach cancer]. Nowotwory (1971) 0.75

[Is the hazard of cancer increased by smoking?]. Wiad Lek (1965) 0.75

[Regional differences in malignant neoplasm mortality in Poland 1975-1976]. Pol Tyg Lek (1981) 0.75

[Changes in malignant neoplasm mortality in Poland during the years 1959-1978]. Nowotwory (1981) 0.75

Somatic mosaicism for a FOXG1 mutation: diagnostic implication. Clin Genet (2013) 0.75

[Comparative studies on the effects of prenylamine, sodium nitritie and bis-(pyridilmethyl)-amine citrate on capillary blood flow in rabbit heart]. Pol Arch Med Wewn (1975) 0.75

Cancer of the urinary bladder: international mortality patterns and trends. World Health Stat Q (1980) 0.75

[Comparison of risk factors in cystic mastopathy, fibroadenoma and carcinoma of the breast]. Nowotwory (1980) 0.75

[Immunosuppressive agents]. Wiad Lek (1970) 0.75

[Acute myocarditis and myocardial infarct in the course of influenza]. Wiad Lek (1972) 0.75

[Attempt of evaluation of the correlation of some factors with the distribution of female breast cancer in Poland]. Nowotwory (1969) 0.75

[Lung cancer mortality and smoking and air pollution in Poland]. Przegl Epidemiol (1968) 0.75

[Increase in breast cancer mortality in females in Poland]. Nowotwory (1970) 0.75

[Mortality in uterine cancer in Poland in the years 1959-67]. Ginekol Pol (1969) 0.75

[Use of the relativesurvival percentage in the evaluation of therapeutic results]. Nowotwory (1974) 0.75

[Is the incidence of stomach cancer in Poland on the increase?]. Nowotwory (1969) 0.75

[Attempt at administering chlorpropamide in the treatment of diabetes insipidus]. Wiad Lek (1970) 0.75

[Parity of women and the most frequent localization of neoplasms]. Ginekol Pol (1971) 0.75

Demographic background to migrant studies in Southeast Asia. Isr J Med Sci (1971) 0.75

[Value of the studies on neoplasm incidence for the determination of their etiology]. Nowotwory (1983) 0.75

[Regional differences of registered mortality on malignant neoplasms in Poland in 1961]. Nowotwory (1968) 0.75

[Regional differences in the mortality from malignant neoplasms in Poland in the years 1961 and 1970-1971]. Nowotwory (1975) 0.75

[The part played by adrenergic receptors in the effect of glucocorticoids on the cardiovascular system]. Pol Tyg Lek (1972) 0.75

[Breast cancer and environmental and host factors]. Nowotwory (1968) 0.75

Cancer mortality statistics for migrants in Southeast Asia. Isr J Med Sci (1971) 0.75

[Regional differences of uterine cancer mortality in relation to fertility and to the age of marriage]. Nowotwory (1968) 0.75

[Mortality from malignant tumors of the upper alimentary tract and the respiratory system in Polish emigrants]. Pol Tyg Lek (1974) 0.75

[Evaluation of histopathologic diagnoses in a cancer registry]. Pol Tyg Lek (1969) 0.75

[Breast carcinoma and past and coexistent diseases]. Nowotwory (1976) 0.75

A propos of summarizing indices for comparison of cancer incidence data. Neoplasma (1969) 0.75